Publications by authors named "Kenneth Schulz"

Claim this Profile
A
Aligning SPIRIT and SAGER guidelines for equity in clinical trials - Authors' reply.
An-Wen Chan, Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F Schulz

Lancet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPIRIT 2025 Statement: Updated Guideline for Protocols of Randomized Trials.
An-Wen Chan, Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F Schulz

JAMA· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation.
Sally Hopewell, An-Wen Chan, Gary S Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F Schulz

Ewha Med J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.
Sally Hopewell, An-Wen Chan, Gary S Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F Schulz

JAMA· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONSORT 2025 statement: updated guideline for reporting randomized trials.
Sally Hopewell, An-Wen Chan, Gary S Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F Schulz

Nat Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the completeness and transparency of protocols and reports of randomized trials: SPIRIT 2025 and CONSORT 2025.
David Moher, Isabelle Boutron, An-Wen Chan, Sally Hopewell, Asbjørn Hróbjartsson, Kenneth F Schulz

J Clin Epidemiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPIRIT 2025 statement: updated guideline for protocols of randomized trials.
An-Wen Chan, Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F Schulz

Nat Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONSORT 2025 statement: Updated guideline for reporting randomised trials.
Sally Hopewell, An-Wen Chan, Gary S Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F Schulz

PLoS Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The legacy of CONSORT and Douglas G Altman.
Kenneth F Schulz, David Moher

BMJ· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.
Sally Hopewell, An-Wen Chan, Gary S Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F Schulz

BMJ· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONSORT 2025 statement: updated guideline for reporting randomised trials.
Sally Hopewell, An-Wen Chan, Gary S Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F Schulz

BMJ· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONSORT 2025 statement: updated guideline for reporting randomised trials.
Sally Hopewell, An-Wen Chan, Gary S Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F Schulz

Lancet· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPIRIT 2025 statement: Updated guideline for protocols of randomised trials.
An-Wen Chan, Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F Schulz

PLoS Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPIRIT 2025 statement: updated guideline for protocols of randomised trials.
An-Wen Chan, Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F Schulz

BMJ· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials.
Asbjørn Hróbjartsson, Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F Schulz

BMJ· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials.
Ying Wang, Sheri Keitz, Matthias Briel, Paul Glasziou, Romina Brignardello-Petersen, Kenneth F Schulz

BMJ· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.
Ruth Tunn, Isabelle Boutron, An-Wen Chan, Gary S Collins, Asbjørn Hróbjartsson, Kenneth F Schulz

J Clin Epidemiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a topic-specific bibliographic database supporting the updates of SPIRIT 2013 and CONSORT 2010.
Lasse Østengaard, Ariel Barrientos, Isabelle Boutron, An-Wen Chan, Gary Collins, Kenneth F Schulz

Cochrane Evid Synth Methods· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compelling evidence from meta-epidemiological studies demonstrates overestimation of effects in randomized trials that fail to optimize randomization and blind patients and outcome assessors.
Ying Wang, Sameer Parpia, Rachel Couban, Qi Wang, Susan Armijo-Olivo, Kenneth F Schulz

J Clin Epidemiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A scoping review identifies multiple comments suggesting modifications to SPIRIT 2013 and CONSORT 2010.
Camilla H Nejstgaard, Isabelle Boutron, An-Wen Chan, Ryan Chow, Sally Hopewell, Kenneth F Schulz

J Clin Epidemiol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issues.
Ying Wang, Maryam Ghadimi, Qi Wang, Liangying Hou, Dena Zeraatkar, Kenneth F Schulz

J Clin Epidemiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials.
Sally Hopewell, Isabelle Boutron, An-Wen Chan, Gary S Collins, Jennifer A de Beyer, Kenneth F Schulz

Nat Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
Aaron M Orkin, Peter J Gill, Davina Ghersi, Lisa Campbell, Jeremy Sugarman, Kenneth F Schulz

JAMA· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
Laureen M Lopez, David A Grimes, Kenneth F Schulz

Cochrane Database Syst Rev· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement.
Edmund Juszczak, Douglas G Altman, Sally Hopewell, Kenneth Schulz

JAMA· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis